Rhapsido
Rhapsido is a medicine authorised by Swissmedic under authorisation number 70227. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 June 2026 and the authorisation is limited until 18 June 2031. ATC code L04AA60 places the medicine in the group Immunosuppressants.
| Authorisation number | 70227 |
|---|---|
| Name | Rhapsido |
| Full name | Rhapsido, Filmtabletten |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AA60 |
| First authorisation | 19 June 2026 |
| Authorisation validity | 18 June 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rhapsido, Filmtabletten | B | 19 June 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Tablette(n) | L04AA60 | 07.15.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Rhapsido authorised in Switzerland?
Yes. Rhapsido is authorised by Swissmedic under authorisation number 70227, data as of 01 September 2026. The authorisation is limited until 18 June 2031.
Which dispensing category does Rhapsido have?
Rhapsido is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rhapsido?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.